Targeting the FGF23-Klotho endocrine axes might have therapeutic benefit for diseases of kidney in clinics.36 Whether blocking of FGF23 activities in patients with end-stage renal disease is an effective therapy to improve symptoms needs to be further studied. Here, KL is linked to chronic kidney disease.